Cal-Maine Foods Reports Results for Third Quarter Fiscal 2023
Cal-Maine Foods reported robust results for Q3 fiscal 2023, achieving net sales of $997.5 million and a net income of $323.2 million, or $6.62 per diluted share. This marks a significant increase from $477.5 million in sales and $39.5 million in net income during the same period last year. The quarterly cash dividend is set at $2.20 per share. Strong conventional egg prices, driven by ongoing avian influenza impacts, supported these results. However, the company faces rising costs in feed and operations due to inflation and market volatility. Total egg sales grew 1.3%, with specialty eggs representing 35.7% of total sales, up from 33.1% the previous year.
- Net sales increased to $997.5 million from $477.5 million YoY.
- Net income rose to $323.2 million, or $6.62 per diluted share, up from $39.5 million.
- Quarterly cash dividend of $2.20 per share reflects strong financial performance.
- Specialty egg sales grew 9.4% YoY, representing 35.7% of total sales.
- Conventional egg volumes sold decreased by 2.7% YoY.
- Farm production costs per dozen increased by 18.2% due to rising feed costs.
Announces Quarterly Cash Dividend of
Third Quarter Fiscal 2023 Highlights
-
Quarterly net sales of
, driven by strong conventional egg prices$997.5 million -
Quarterly net income of
, or$323.2 million per basic and$6.64 per diluted common share$6.62 -
Cash dividend of
, or$107.7 million per share, pursuant to the Company’s established dividend policy$2.20
Overview
“The domestic egg market has always been intensely competitive and highly volatile even under normal market circumstances. At
“We have worked hard to respond to the challenging operating environment, targeting optimal management of every aspect of our business within our control. As always, we are focused on the long-term, working within the proven operating model that has served us well throughout the various cycles that characterize our industry. In combination with the current inflationary environment, the HPAI epidemic has created additional challenges for all producers, with increasing costs and supply chain disruptions. We are grateful to our dedicated managers and employees across our production facilities who have efficiently managed our operations during this time. We have invested substantial capital and management resources in our biosecurity measures, and these investments, along with our employees’ diligent adherence to our robust biosecurity protocols, have allowed us to continue to produce and bring more quality eggs to the market. There have been no positive tests for HPAI at any Cal-Maine Foods’ owned or contracted production facility as of
Sales Performance & Operating Highlights
Conventional egg net average selling price per dozen increased to
For the third quarter of fiscal 2023, total dozens sold increased
This increase in demand for specialty eggs was positively affected by the higher conventional egg prices as compared to the same period in the prior year. Conventional egg prices exceeding specialty egg prices has occurred for the past four quarters but is atypical historically.
The Company reported operating income of
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Dozen Eggs Sold (000) |
|
291,416 |
|
|
|
287,651 |
|
|
|
850,819 |
|
|
|
811,821 |
|
Conventional Dozen Eggs Sold (000) |
|
187,357 |
|
|
|
192,511 |
|
|
|
555,045 |
|
|
|
568,511 |
|
Specialty Dozen Eggs Sold (000) |
|
104,059 |
|
|
|
95,140 |
|
|
|
295,774 |
|
|
|
243,310 |
|
Dozen Eggs Produced (000) |
|
263,174 |
|
|
|
264,433 |
|
|
|
782,186 |
|
|
|
757,677 |
|
% Specialty Sales (dozen) |
|
35.7 |
% |
|
|
33.1 |
% |
|
|
34.8 |
% |
|
|
30.0 |
% |
% Specialty Sales (dollars) |
|
28.2 |
% |
|
|
39.4 |
% |
|
|
29.6 |
% |
|
|
40.2 |
% |
Net Average Selling Price (per dozen) |
$ |
3.298 |
|
|
$ |
1.612 |
|
|
$ |
2.771 |
|
|
$ |
1.412 |
|
Net Average Selling Price Conventional Eggs (per dozen) |
$ |
3.678 |
|
|
$ |
1.458 |
|
|
$ |
2.984 |
|
|
$ |
1.203 |
|
Net Average Selling Price Specialty Eggs (per dozen) |
$ |
2.616 |
|
|
$ |
1.923 |
|
|
$ |
2.369 |
|
|
$ |
1.900 |
|
Feed Cost (per dozen) |
$ |
0.679 |
|
|
$ |
0.562 |
|
|
$ |
0.677 |
|
|
$ |
0.546 |
|
Product Mix & Cage-Free Eggs
As demand for specialty eggs, particularly cage-free eggs, has evolved, the Company has focused on meeting current and expected customer demand. A significant number of Cal-Maine Foods’ customers previously announced goals to offer cage-free eggs exclusively on or before 2026. While some of these customers have extended those timelines to the end of 2030, the Company’s priority is to work with its customers to facilitate a smooth transition to their announced timelines for cage-free egg sales.
Table Egg Supply Outlook
The current HPAI epidemic has surpassed the prior 2014-2015 outbreak in terms of its duration and the number of affected hens in the
The Company believes the HPAI outbreak will continue to exert downward pressure on the overall supply of eggs, and the duration of these effects will depend in part on the timing of replenishment of the
Dividend Payment
For third quarter of fiscal 2023,
About
Forward Looking Statements
Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s
|
||||||||||||||||
FINANCIAL HIGHLIGHTS |
||||||||||||||||
(Unaudited) |
||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||
SUMMARY STATEMENTS OF OPERATIONS |
||||||||||||||||
|
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net sales |
|
$ |
997,493 |
|
|
$ |
477,485 |
|
|
$ |
2,457,537 |
|
|
$ |
1,184,195 |
|
Cost of sales |
|
|
534,467 |
|
|
|
385,903 |
|
|
|
1,459,172 |
|
|
|
1,042,221 |
|
Gross profit |
|
|
463,026 |
|
|
|
91,582 |
|
|
|
998,365 |
|
|
|
141,974 |
|
Selling, general and administrative |
|
|
58,489 |
|
|
|
52,686 |
|
|
|
170,048 |
|
|
|
146,991 |
|
Insurance recoveries |
|
|
(3,220 |
) |
|
|
(1,095 |
) |
|
|
(3,220 |
) |
|
|
(3,225 |
) |
(Gain) loss on disposal of fixed assets |
|
|
(26 |
) |
|
|
421 |
|
|
|
36 |
|
|
|
370 |
|
Operating income (loss) |
|
|
407,783 |
|
|
|
39,570 |
|
|
|
831,501 |
|
|
|
(2,162 |
) |
Other income, net |
|
|
17,104 |
|
|
|
13,478 |
|
|
|
21,134 |
|
|
|
21,814 |
|
Income before income taxes |
|
|
424,887 |
|
|
|
53,048 |
|
|
|
852,635 |
|
|
|
19,652 |
|
Income tax expense (benefit) |
|
|
102,118 |
|
|
|
13,594 |
|
|
|
206,438 |
|
|
|
(2,921 |
) |
Net income |
|
|
322,769 |
|
|
|
39,454 |
|
|
|
646,197 |
|
|
|
22,573 |
|
Less: Loss attributable to noncontrolling interest |
|
|
(450 |
) |
|
|
(63 |
) |
|
|
(896 |
) |
|
|
(91 |
) |
Net income attributable to |
|
$ |
323,219 |
|
|
$ |
39,517 |
|
|
$ |
647,093 |
|
|
$ |
22,664 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
6.64 |
|
|
$ |
0.81 |
|
|
$ |
13.31 |
|
|
$ |
0.46 |
|
Diluted |
|
$ |
6.62 |
|
|
$ |
0.81 |
|
|
$ |
13.25 |
|
|
$ |
0.46 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
48,653 |
|
|
|
48,886 |
|
|
|
48,634 |
|
|
|
48,888 |
|
Diluted |
|
|
48,842 |
|
|
|
49,036 |
|
|
|
48,832 |
|
|
|
49,035 |
|
|
||||||
FINANCIAL HIGHLIGHTS |
||||||
(Unaudited) |
||||||
(In thousands) |
||||||
SUMMARY BALANCE SHEETS |
||||||
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
645,032 |
|
$ |
174,513 |
Receivables, net |
|
|
249,867 |
|
|
219,404 |
Inventories, net |
|
|
290,869 |
|
|
263,316 |
Prepaid expenses and other current assets |
|
|
7,599 |
|
|
4,286 |
Current assets |
|
|
1,193,367 |
|
|
661,519 |
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
712,512 |
|
|
677,796 |
Other noncurrent assets |
|
|
86,604 |
|
|
88,174 |
Total assets |
|
$ |
1,992,483 |
|
$ |
1,427,489 |
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
$ |
205,340 |
|
$ |
148,018 |
Dividends payable |
|
|
107,720 |
|
|
36,656 |
Current liabilities |
|
|
313,060 |
|
|
184,674 |
|
|
|
|
|
|
|
Deferred income taxes and other liabilities |
|
|
144,535 |
|
|
138,470 |
Stockholders' equity |
|
|
1,534,888 |
|
|
1,104,345 |
Total liabilities and stockholders' equity |
|
$ |
1,992,483 |
|
$ |
1,427,489 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230328005791/en/
(601) 948-6813
Source:
FAQ
What were Cal-Maine Foods' Q3 fiscal 2023 sales figures?
What was the net income for Cal-Maine Foods in Q3 fiscal 2023?
What dividend did Cal-Maine Foods declare for Q3 fiscal 2023?
How did specialty egg sales perform in Q3 fiscal 2023?